• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: STRYKER NEUROVASCULAR CORK TARGET 360 NANO 2 MM X 3 CM; DEVICE, NEUROVASCULAR EMBOLIZATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

STRYKER NEUROVASCULAR CORK TARGET 360 NANO 2 MM X 3 CM; DEVICE, NEUROVASCULAR EMBOLIZATION Back to Search Results
Catalog Number M0035442030
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Transient Ischemic Attack (2109)
Event Date 12/21/2017
Event Type  Injury  
Manufacturer Narrative
This is the second of 2 reports.The patient event reported under this filling occured more than 3 month post-procedure and is related to another reported event that occurred 1 month post procedure filed under mfr report # 3008881809-2017-00440.The device history record (dhr) review confirms that the device met all material, assembly and performance specifications.The subject device was not returned for analysis; therefore, physical as well as a functional testing could not be performed.However, tia (transient ischemic attack) is a known risk associated with endovascular procedures and noted as such in the device directions for use (dfu).Therefore, an assignable cause of anticipated procedural complication was assigned to this event.Subject devices remain implanted.
 
Event Description
The patient underwent successful stent-assisted coil embolization of an un-ruptured aneurysm located in the left superior cerebellar artery.Post procedure the patient was neurologically assessed having a nihss of 0 and a mrs of 1.More than 3 month post-procedure, that patient experience a transient ischemic attack (tia) that was resolved the next day without residual effect.Medication hospitalization/prolonged hospitalization was undertaken.According to the physician, the tia were possibly related to the procedure and the stent.However it is unknown if the tia was related to the 2 implanted coils (subject devices).The patient was neurologically assessed at 2 month post procedure having a nihss of 0 and a mrs of 1.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TARGET 360 NANO 2 MM X 3 CM
Type of Device
DEVICE, NEUROVASCULAR EMBOLIZATION
Manufacturer (Section D)
STRYKER NEUROVASCULAR CORK
ida industrial estate
model farm road
cork NA
Manufacturer (Section G)
STRYKER NEUROVASCULAR CORK
ida industrial estate
model farm road
cork NA
Manufacturer Contact
tara lopez
47900 bayside parkway
fremont, CA 94538
5104132500
MDR Report Key7201593
MDR Text Key97593886
Report Number3008881809-2018-00045
Device Sequence Number1
Product Code HCG
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K153658
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type study
Reporter Occupation Physician
Type of Report Initial
Report Date 01/17/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date02/29/2020
Device Catalogue NumberM0035442030
Device Lot Number19621521
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 12/26/2017
Initial Date FDA Received01/17/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured02/20/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
NEUROFORM ATLAS STENT (STRYKER); TARGET COIL (STRYKER)
Patient Outcome(s) Hospitalization; Other;
Patient Age62 YR
-
-